Lonza Capacity Update October 2024: Small Molecule

The growing complexity of small molecule active pharmaceutical ingredients (APIs) is creating challenges for innovators, with longer synthetic routes and supply chains often delaying preclinical development. To address this, Lonza Small Molecules has introduced its AI-Enabled Route Scouting Service, a cutting-edge solution utilizing advanced computer-aided synthesis planning (CASP) technology. This service empowers process chemists to identify the most efficient synthetic routes, streamlining development and enhancing supply chain resilience.

By combining proprietary data with AI-driven tools, Lonza’s approach optimizes route selection, accelerates development timelines, and refines supply chain strategies. The service is tailored to meet the specific needs of each project, supporting a quicker path to clinical readiness while maintaining high standards of flexibility and quality. By reducing synthetic complexity and fostering informed decision-making, Lonza’s Route Scouting Service serves as a vital resource in accelerating IND submissions and ensuring the timely delivery of innovative therapeutics. This discussion will explore how Lonza’s customized methodology mitigates API complexity, boosts process efficiency, and delivers strategic value throughout the pharmaceutical development lifecycle.